Association of Secondary Primary Malignancies in Cutaneous Lymphoma: A Narrative Review
Open Access
- 11 December 2025
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 15 (24) , 3150
Abstract
Cutaneous lymphomas are a heterogeneous group of extranodal non-Hodgkin lymphomas with distinct clinical and biological features, broadly classified into cutaneous T-cell lymphomas (CTCL) and cutaneous B-cell lymphomas (CBCL). With improved survival due to early detection and therapeutic advances, the emergence of second primary malignancies (SPMs) has become a clinical concern. SPMs, defined as new, distinct malignant neoplasms arising synchronously or metachronously with the index cancer, can significantly impair prognosis and quality of life. In this narrative review, we meticulously examine the current literature, to synthesize evidence on SPMs’ incidence and risk factors in patients with primary cutaneous lymphomas. Evidence from population-based and institutional studies consistently demonstrates elevated risks of hematologic and solid tumors in CTCL. By contrast, data on CBCL remain limited, though recent population-based analyses suggest increased risks of certain hematologic malignancies and solid tumors. We further propose development mechanisms for SPMs, including treatment-related mutagenesis, shared genetic susceptibilities, chronic antigenic stimulation, and immune dysregulation. Lastly, we highlight the clinical implications of these findings, underscoring the need for vigilant surveillance, patient education, and tailored screening strategies. Future research should prioritize large-scale, prospective, and molecularly integrated studies to refine risk stratification and guide personalized survivorship care of this vulnerable population.Keywords
This publication has 91 references indexed in Scilit:
- Secondary Cancer Risk Among Patients With Primary Cutaneous B-cell LymphomaJAMA Dermatology, 2025
- Overall and Cause‐Specific Mortality Among Patients With Cutaneous T‐Cell Lymphoma in the United StateseJHaem, 2025
- Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and managementAmerican Journal of Hematology, 2022
- High Frequency and Clinical Prognostic Value of MYD88 L265P Mutation in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-TypeJAMA Dermatology, 2014
- Outcomes After Diagnosis of Mycosis Fungoides and Sézary Syndrome Before 30 Years of AgeJAMA Dermatology, 2014
- Second Lymphomas and Other Malignant Neoplasms in Patients With Mycosis Fungoides and Sézary SyndromeArchives of Dermatology, 2007
- Secondary Malignant Neoplasms in 71 Patients With Sézary SyndromeArchives of Dermatology, 1999
- Increased risk of lymphoid and nonlymphoid malignancies in patients with lymphomatoid papulosisCancer, 1999
- Malignant Melanoma and Other Second Cutaneous Malignancies in Cutaneous T-Cell LymphomaArchives of Dermatology, 1995
- Risk of second malignancy after cutaneous T-cell lymphomaCancer, 1989